CPhI Barcelona
Come visit us (stand 2P28 and 3N76) at CPhI Worldwide from 4-6 October in Fira de Barcelona in Spain.
Menu
Nipro recognizes the importance of environmental preservation and acts conscientiously.
Active involvement in environmental issues is an essential part of corporate activity. We keep an eye on our potential impact on the global environment not in the manufacturing process alone, but in all aspects of our business activities. In our efforts to preserve and improve the environment, we pursue efficient use of resources and energy, reduction of waste and emissions, assessment and mitigation of the impact of our products and production process on the environment, and development and use of environmental technologies.
We take swift and appropriate action to alleviate any adverse impact or potential impact on the environment and to improve the environment. We also cooperate with the local community in environmental activities, and provide fair and appropriate information.
To help reduce environmental burden we promote recycling, lights-off and other conservation activities that can easily be done on a daily basis.
Nipro promotes various activities at its offices and factories to reduce burdens on the global environment. Recognizing environmental conservation as a key issue, each and every worker is actively involved in eco-friendly initiatives, such as conservation and reuse of resources, and energy-saving campaigns for lighting and air-conditioning systems.
In each business area of Nipro Corporation, priority is focused on building long-term partnerships with each customer. This is accomplished by providing superior quality and value throughout the business in addition to listening to customer needs and translating those needs into specific products and services. Nipro Europe constantly thrives to create and offer safe, high-quality products ensuring a better quality of life. Being recognized as a worldwide leading brand vital to the medical field of artificial organs, regenerative medicines and other medical devices, we continue to strive for growth by becoming our customer’s first choice.
…we offer an organization that is attractive and challenging. We strive for operational excellence through an experienced and talented employee base. We empower and provide our people with the resources needed to develop professionally, improving their skills, resulting in a dedicated team.
…we manage a portfolio that is focused on customer and market demand. We always strive to expand in new and current markets with innovative products and applications. By continuously increasing our positioning efforts, we enlarge our brand name recognition.
…we are a sales and marketing-focused organization, committed to continuously advancing our efficiency and improving our work to provide superior products and services.
Kurt Van Dal CEO/presidentMedical devices are now a pervasive part of modern medical care. They are in many cases associated with quality of care. Healthcare worker and patient safety are key strategies for healthcare providers. Nipro assists providers to meet this challenge by supplying a developing portfolio of next generation safety medical products aimed at reducing the risk of needlestick injuries and associated infections.
Nipro’s quality system is focused on satisfying critical specifications, continuously improving all products and complying with regulatory requirements. Regulatory services include 510(k) and technical file preparation and assistance with CE Marking.
“Our customers expect the highest quality products and materials, made for their specific needs, and delivered in a short time frame.”
| Company Name | Address | Postal Code | Place | Country | Tel | Fax | |
|---|---|---|---|---|---|---|---|
| Nipro Pure Water GmbH | Werner-von-Siemens-Str. 2-6 | 76646 | Bruchsal | Germany | +49 7251 / 32 19 78 10 | +49 7251 / 61 89 94 3 | info@nipropurewater.com |
| Nipro Renal Solutions | Pol.Ind. TUMSA - nave 31 | 25230 | Mollerusa (Lleida) | Spain | +34 973 710 758 | +34 973 711 500 | info@niprorenalsolutions.com |
| Nipro Europe France | Biopôle Clermont-Limange | 63 360 | Saint Beauzire | France | +33 473 33 41 00 | +00 473 33 41 09 | |
| Nipro Europe Netherlands | Regus Business Center - Verlengde Poolse Weg 16 | 4818 CL | Breda | Netherlands | +31 76 524 50 99 | +31 76 524 46 66 | |
| Nipro Europe Poland | Ul. Pańska 73 | 00-834 | Warszawa | Poland | +48 22 31 47 155 | +48 22 31 47 152 | |
| Nipro Europe Spain | Poligono Los Frailes n° 93 y 94 - Daganzo | 28814 | Madrid | Spain | +34 91 884 5531 | +34 91 878 2840 | |
| Nipro Europe Russia | 12 Krasnopresnenskaya Nab. Office 1408, entrance 6 | 123610 | Moscow | Russia | +7 495 258 1364 | +7 495 258 1367 | |
| Nipro Europe Italy | Centro Direzionale Milanofiori Strada 1 - Palazzo F/1 | 20090 | Assago (Milano) | Italy | +39 02 57 50 00 57 | +39 02 57 51 81 11 | |
| Nipro Nordics AB | Stortorget 13B | 211 22 | Mälmo | Sweden | +46 40 60 61 250 | +46 50 60 61 255 | |
| Nipro Senegal SUARL | 27 Avenue Georges Pompidou | Dakar | Senegal |
The Nipro Group promotes research and development of both medical equipment and pharmaceutical products.
Our research and development focuses on cutting-edge technologies as well as trying to achieve higher quality and improved functionality with our existing products. We expect to commercialize one of our cutting-edge products, namely our nerve regeneration-assisting device, which uses our unique bio-absorbable materials, developed in-house.
We have come close to developing a cell-culturing system thanks to our studies of stem cells in umbilical blood.
In terms of artificial organs, our range of implanted ventricular-assist devices, developed in cooperation with an American company, are currently at the clinical testing stage in Japan.
With regard to the development of new drugs and new formulation technologies, further to the commercialization of our powdered dialysis solutions based on a new and highly effective granulation technology, we plan to be the first company to commercialize a double-bag product for hemodiafiltration substitution fluids as well as selling various products such as pre-filled syringes for safety use, thereby contributing to the prevention of medical accidents.
In this consolidated accounting year, the total cost of R&D activity was 4.8 billion yen (US$ 52.1 million).
Nipro offers you the opportunity to join one of its four Business units and be part of a leading brand. Whether you are an Account Manager with Hospital Products, a Customer Services Representative at headquarters or a Clinical Support Specialist with Renal Care you will find a career with Nipro that will challenge your thinking, develop your professional skills and brings you into contact with people who share the same commitment to simplicity and service.
We’re continually seeking talented individuals at all levels. Nipro offers excellent opportunities within sales, marketing, finance and technical departments for all of its European offices.
Nipro Europe is committed to equal opportunity in employment, and is opposed to discrimination of employees or applicants for employment, on the grounds of race, religious beliefs, colour, nationality, sex, sexual orientation, marital/parental status, age, or disability.
